Celldex Therapeutics, Inc. · NASDAQ:CLDX

Commodore Capital LP's stake in Celldex Therapeutics, Inc. fell to 4.60% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Commodore Capital LP's stake in Celldex Therapeutics, Inc. fell to 4.60%, 3,028,335 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
4.60%
Shares
3,028,335
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Commodore Capital LP4.60%3,028,335
Commodore Capital Master LP4.60%3,028,335

Source

View original at SEC

Related